Full text is available at the source.
Abstract
An executive order has been issued to support the development and approval of psychedelic drugs.
- The integration of psychedelic drugs into clinical care raises ethical concerns.
- There is an ongoing discussion about the evidence base for the use of these substances in medicine.
- Issues related to regulation and safety are critical for the approval process of psychedelic therapies.
Simplified
Psychedelic Science